Blueprint Medicines Corp. (2L9)
Delisted
XBER XBER Primary Want to track 2L9 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
2L9 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XBER (EUR).
2025 © Marketlog. All Rights Reserved.
